Organogenesis Holdings Inc
ORGO5.630USD
+1.740+44.73%
Cierre 11/07, 16:00（ET）Cotizaciones retrasadas 15 min
714.51MCap. mercado
PérdidaP/E TTM
Más Datos de Organogenesis Holdings Inc Compañía
Organogenesis Holdings Inc. is a regenerative medicine company focused on the development, manufacture and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. It offers a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. Its advanced wound care products include Apligraf for the treatment of venous leg ulcers and diabetic foot ulcers (DFUs); Dermagraft for the treatment of DFUs; PuraPly AM as an antimicrobial barrier and native, cross-linked extracellular matrix scaffold for a variety of wound types; and Affinity, Novachor and NuShield placental allografts to address a variety of wound sizes and types. Sports Medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM and PuraPly SX for management of open wounds in the surgical setting.
Información de Organogenesis Holdings Inc
Símbolo de cotizaciónORGO
Nombre de la empresaOrganogenesis Holdings Inc
Fecha de salida a bolsaDec 02, 2016
Director ejecutivoMr. Gary S. Gillheeney, Sr.
Número de empleados869
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 02
Dirección85 Dan Rd
CiudadCANTON
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal02021-2810
Teléfono17815750775
Sitio Webhttps://investors.organogenesis.com
Símbolo de cotizaciónORGO
Fecha de salida a bolsaDec 02, 2016
Director ejecutivoMr. Gary S. Gillheeney, Sr.
Ejecutivos de Organogenesis Holdings Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Glenn H. Nussdorf
Mr. Glenn H. Nussdorf
Director
Director
12.25M
+2.82%
Mr. Patrick Bilbo
Mr. Patrick Bilbo
Chief Operating Officer
Chief Operating Officer
447.51K
-8.12%
Mrs. Lori Freedman, J.D.
Mrs. Lori Freedman, J.D.
Chief Administrative and Legal Officer
Chief Administrative and Legal Officer
419.71K
+150.65%
Mr. Brian Grow
Mr. Brian Grow
Chief Commercial Officer
Chief Commercial Officer
202.42K
+0.94%
Mr. Robert Cavorsi
Mr. Robert Cavorsi
Vice President - Strategy
Vice President - Strategy
189.16K
-0.19%
Mr. Antonio S. Montecalvo
Mr. Antonio S. Montecalvo
Vice President - Health Policy
Vice President - Health Policy
188.20K
+17.78%
Mr. Arthur S. Leibowitz, CPA
Mr. Arthur S. Leibowitz, CPA
Lead Independent Director
Lead Independent Director
187.61K
+0.78%
Ms. Prathyusha Duraibabu, CPA
Ms. Prathyusha Duraibabu, CPA
Independent Director
Independent Director
148.64K
+3.64%
Mr. Jon L. Giacomin
Mr. Jon L. Giacomin
Independent Director
Independent Director
142.62K
+2.31%
Dr. Gilberto Quintero, Ph.D.
Dr. Gilberto Quintero, Ph.D.
Independent Director
Independent Director
140.67K
+1.04%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Glenn H. Nussdorf
Mr. Glenn H. Nussdorf
Director
Director
12.25M
+2.82%
Mr. Patrick Bilbo
Mr. Patrick Bilbo
Chief Operating Officer
Chief Operating Officer
447.51K
-8.12%
Mrs. Lori Freedman, J.D.
Mrs. Lori Freedman, J.D.
Chief Administrative and Legal Officer
Chief Administrative and Legal Officer
419.71K
+150.65%
Mr. Brian Grow
Mr. Brian Grow
Chief Commercial Officer
Chief Commercial Officer
202.42K
+0.94%
Mr. Robert Cavorsi
Mr. Robert Cavorsi
Vice President - Strategy
Vice President - Strategy
189.16K
-0.19%
Mr. Antonio S. Montecalvo
Mr. Antonio S. Montecalvo
Vice President - Health Policy
Vice President - Health Policy
188.20K
+17.78%
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
Por negocioUSD
Nombre
Ganancia
Proporción
Advanced Wound Care
92.70M
91.98%
Surgical & Sports Medicine
8.08M
8.02%
Sin datos
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Advanced Wound Care
92.70M
91.98%
Surgical & Sports Medicine
8.08M
8.02%
Estadísticas de accionistas
Actualizado: mar., 19 de ago
Actualizado: mar., 19 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Soleus Capital Management, L.P.
9.73%
Nussdorf (Glenn H)
9.65%
Morgan Stanley & Co. LLC
9.44%
Ades (Alan A)
8.82%
Erani (Dennis)
7.91%
Otro
54.45%
Accionistas
Accionistas
Proporción
Soleus Capital Management, L.P.
9.73%
Nussdorf (Glenn H)
9.65%
Morgan Stanley & Co. LLC
9.44%
Ades (Alan A)
8.82%
Erani (Dennis)
7.91%
Otro
54.45%
Tipos de accionistas
Accionistas
Proporción
Individual Investor
32.98%
Investment Advisor
18.24%
Investment Advisor/Hedge Fund
15.90%
Corporation
14.12%
Hedge Fund
11.28%
Research Firm
10.23%
Pension Fund
0.57%
Bank and Trust
0.14%
Sovereign Wealth Fund
0.05%
Participación institucional
Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
284
71.59M
56.41%
-2.03M
2025Q2
303
127.55M
100.55%
+5.63M
2025Q1
324
125.21M
99.06%
+1.00M
2024Q4
344
121.01M
95.72%
-4.65M
2024Q3
354
109.09M
82.30%
-7.23M
2024Q2
369
107.79M
81.32%
-6.45M
2024Q1
374
102.47M
77.65%
-12.90M
2023Q4
378
102.14M
77.80%
-10.89M
2023Q3
390
113.75M
86.92%
-11.36M
2023Q2
400
112.98M
86.34%
-14.25M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Soleus Capital Management, L.P.
12.34M
9.73%
-135.00K
-1.08%
Jun 30, 2025
Nussdorf (Glenn H)
11.91M
9.39%
--
--
Jun 24, 2025
Morgan Stanley & Co. LLC
11.98M
9.45%
-50.05K
-0.42%
Jun 30, 2025
Ades (Alan A)
11.19M
8.82%
--
--
Jun 24, 2025
Erani (Dennis)
10.04M
7.92%
--
--
Jun 24, 2025
Organo PFG LLC
8.28M
6.53%
--
--
Jun 24, 2025
RED Holdings, L.L.C.
6.78M
5.35%
--
--
Jun 24, 2025
First Light Asset Management, LLC
6.78M
5.34%
+6.78M
--
Jun 30, 2025
The Vanguard Group, Inc.
5.20M
4.1%
+765.38K
+17.27%
Jun 30, 2025
Assenagon Asset Management S.A.
4.85M
3.83%
+2.00M
+69.88%
Sep 30, 2025
Ver más
ETFs relacionados
Actualizado: jue., 6 de nov
Actualizado: jue., 6 de nov
Nombre
Proporción
WisdomTree US SmallCap Fund
0.12%
iShares Micro-Cap ETF
0.06%
Franklin US Small Cap Multifactor Index ETF
0.05%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.05%
Vanguard US Momentum Factor ETF
0.04%
Fidelity Enhanced Small Cap ETF
0.03%
Avantis US Small Cap Equity ETF
0.03%
iShares Russell 2000 Growth ETF
0.02%
Invesco RAFI US 1500 Small-Mid ETF
0.02%
iShares Morningstar Small-Cap Value ETF
0.01%
Ver más
WisdomTree US SmallCap Fund
Proporción0.12%
iShares Micro-Cap ETF
Proporción0.06%
Franklin US Small Cap Multifactor Index ETF
Proporción0.05%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporción0.05%
Vanguard US Momentum Factor ETF
Proporción0.04%
Fidelity Enhanced Small Cap ETF
Proporción0.03%
Avantis US Small Cap Equity ETF
Proporción0.03%
iShares Russell 2000 Growth ETF
Proporción0.02%
Invesco RAFI US 1500 Small-Mid ETF
Proporción0.02%
iShares Morningstar Small-Cap Value ETF
Proporción0.01%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
